News
Clinical Trials Arena on MSN2d
US FDA approves BlackfinBio’s gene therapy trial for hereditary spastic paraplegiaThe US FDA has cleared BlackfinBio's application for a Phase I/II trial of BFB-101, an AAV gene therapy designed to treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback